Osteoporosis postmenopausal

This trial investigates whether a single or repeat infusion of zoledronate, or daily oral alendronate, can maintain the bone density improvements achieved with denosumab in postmenopausal women with osteoporosis. Participants who have been on denosumab for at least three years wi…

This study looks at whether adding the drug abaloparatide (Tymlos) to the standard treatment denosumab (Prolia) can improve bone density more than denosumab alone in postmenopausal women with osteoporosis. Seventy women who have already been on denosumab will either continue with…

This study tests whether a year of monthly injections of romosozumab, followed by an infusion of zoledronic acid, can improve bone density and prevent fractures in women aged 65 and older with osteoporosis who live in long-term care facilities. The goal is to find a treatment tha…

This study looks at whether giving zoledronate infusions can prevent bone loss in postmenopausal women who have stopped taking denosumab for osteoporosis. About 200 women who took denosumab for at least two years will receive zoledronate at different times. The goal is to find th…

This study tests whether balance training done at home via video calls works as well as in-person sessions for postmenopausal women with osteoporosis. Sixty women aged 50-70 with low bone density and balance issues will be randomly assigned to either remote or traditional trainin…

This study was designed to test whether adding arm exercises to a standard osteoporosis medication could improve bone density in the wrist. It was planned for postmenopausal women at high fracture risk. However, the study was withdrawn before enrolling any participants, so no res…